SARAH NELSON: Open Payments
NPI 1801445457 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 12 payments from 9 companies in 2025. Trend: 2023 $644 · 2024 $155 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $57 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Adaptive Biotechnologies Corporation | 1 | $29 |
| Astellas Pharma US Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: JAKAFI, clonoSEQ, REBLOZYL, Vyloy, NINLARO, OJJAARA, Flexitouch Plus, MONJUVI.
Industry payments across LA — which companies pay providers there.
